论文信息 - Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown - 字舞流文

Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown

Ricardo J. Miragaia | Y. Shrestha | J. Barrett | R. Miragaia | A. Gupta | P. Dennis | R. Raja | M. Jure-Kunkel | R. Herbst | M. Frigault | M. Oberst | M. Griffin | K. Mulgrew | N. Standifer | M. D. L. Reyes | M. Ascierto | N. Pore | I. Bisha | S. Blackmore | S. Abdullah | John H. Meekin | Philip Martin | Song Wu | R. Halpin | R. Rothstein | Theresa A. Proia | Kathy Mulgrew